Surmodics, Inc (NASDAQ: SRDX) on Tuesday, soared 49.72% from the previous trading day, before settling in for the closing price of $27.34. Within the past 52 weeks, SRDX’s price has moved between $25.87 and $40.38.
The company achieved an average annual earnings per share of 9.38%. With a float of $13.73 million, this company’s outstanding shares have now reached $14.30 million.
Surmodics, Inc (SRDX) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Surmodics, Inc is 3.97%, while institutional ownership is 89.11%. The most recent insider transaction that took place on Nov 26 ’24, was worth 276,453. In this transaction Chief Financial Officer of this company sold 7,009 shares at a rate of $39.44, taking the stock ownership to the 70,350 shares. Before that another transaction happened on Nov 26 ’24, when Company’s Officer proposed sale 7,009 for $39.44, making the entire transaction worth $276,453.
Surmodics, Inc (SRDX) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.13 earnings per share (EPS) for the period topping the consensus outlook (set at -0.29) by 0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.38% per share during the next fiscal year.
Surmodics, Inc (NASDAQ: SRDX) Trading Performance Indicators
Surmodics, Inc (SRDX) is currently performing well based on its current performance indicators. A quick ratio of 3.10 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of Surmodics, Inc (SRDX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.66 million. That was better than the volume of 0.19 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 61.28%.
During the past 100 days, Surmodics, Inc’s (SRDX) raw stochastic average was set at 98.30%, which indicates a significant increase from 98.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.02 in the past 14 days, which was lower than the 1.04 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.79, while its 200-day Moving Average is $30.95. However, in the short run, Surmodics, Inc’s stock first resistance to watch stands at $41.22. Second resistance stands at $41.49. The third major resistance level sits at $41.79. If the price goes on to break the first support level at $40.65, it is likely to go to the next support level at $40.35. The third support level lies at $40.08 if the price breaches the second support level.
Surmodics, Inc (NASDAQ: SRDX) Key Stats
Market capitalization of the company is 585.35 million based on 14,298K outstanding shares. Right now, sales total 126,080 K and income totals -11,540 K. The company made 29,570 K in profit during its latest quarter, and -5,320 K in sales during its previous quarter.
